We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$22.7B
AUM Growth
+$1.49B
Cap. Flow
-$446M
Cap. Flow %
-1.97%
Top 10 Hldgs %
29.86%
Holding
610
New
38
Increased
168
Reduced
251
Closed
125

Sector Composition

Rank Sector Weight
1 Technology 29%
2 Healthcare 21.84%
3 Financials 10.81%
4 Consumer Discretionary 8.93%
5 Communication Services 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.83T
$1.13B 4.98%
2,998,592
+88,462
+3% +$31.5M
UNH icon
2
UnitedHealth
UNH
$385B
$837M 3.69%
1,589,231
+54,511
+4% +$29.1M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$3.89T
$707M 3.12%
5,059,654
+556,625
+12% +$74.8M
META icon
4
Meta Platforms (Facebook)
META
$1.54T
$663M 2.92%
1,871,753
-19,079
-1% -$6.21M
JNJ icon
5
Johnson & Johnson
JNJ
$624B
$625M 2.76%
3,986,364
+241,507
+6% +$37M
AAPL icon
6
Apple
AAPL
$4.72T
$615M 2.72%
3,196,530
+111,072
+4% +$20.5M
AMZN icon
7
Amazon
AMZN
$2.51T
$597M 2.63%
3,926,579
-155,031
-4% -$21.7M
ACN icon
8
Accenture
ACN
$84.9B
$557M 2.46%
1,587,917
+42,113
+3% +$13.6M
TXN icon
9
Texas Instruments
TXN
$260B
$545M 2.4%
3,195,338
+652,150
+26% +$101M
LRCX icon
10
Lam Research
LRCX
$400B
$494M 2.18%
6,312,580
-1,091,110
-15% -$74.4M
KO icon
11
Coca-Cola
KO
$349B
$490M 2.16%
8,323,383
+1,405,260
+20% +$79.8M
ORCL icon
12
Oracle
ORCL
$346B
$484M 2.13%
4,588,539
+148,308
+3% +$16.2M
ABT icon
13
Abbott
ABT
$175B
$482M 2.13%
4,375,357
+710,501
+19% +$71M
CRM icon
14
Salesforce
CRM
$129B
$441M 1.94%
1,674,830
+214,826
+15% +$48.6M
MRK icon
15
Merck
MRK
$322B
$439M 1.94%
4,025,858
-3,058
-0.1% -$317K
ELV icon
16
Elevance Health
ELV
$82.3B
$433M 1.91%
918,761
+28,849
+3% +$13.3M
TJX icon
17
TJX Companies
TJX
$170B
$407M 1.8%
4,342,636
+186,179
+4% +$16.7M
LLY icon
18
Eli Lilly
LLY
$1.06T
$402M 1.77%
689,863
+30,370
+5% +$17.7M
ISRG icon
19
Intuitive Surgical
ISRG
$119B
$383M 1.69%
1,136,532
+232,392
+26% +$69.3M
WFC icon
20
Wells Fargo
WFC
$261B
$364M 1.61%
7,395,836
-354,047
-5% -$15.3M
V icon
21
Visa
V
$669B
$362M 1.6%
1,388,594
+57,263
+4% +$14.1M
OTIS icon
22
Otis Worldwide
OTIS
$27.2B
$348M 1.53%
3,885,044
+436,772
+13% +$36.3M
USB icon
23
US Bancorp
USB
$98.7B
$346M 1.53%
7,986,349
-930,944
-10% -$34M
KLAC icon
24
KLA
KLAC
$286B
$315M 1.39%
5,415,830
+199,490
+4% +$10.4M
DAR icon
25
Darling Ingredients
DAR
$10.1B
$257M 1.14%
5,165,384
+409,523
+9% +$18.6M

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2023 Portfolio in Review

As of Q4 2023, Grantham, Mayo, Van Otterloo & Co (GMO) held 610 positions worth $22.7B, up 7% from $21.2B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2023 filing shows 38 new, 168 increased, 251 reduced and 125 closed positions. Its largest new stake was Pioneer Natural Resource Co.: 240,096 shares worth $54M. The largest sale was Adobe, an estimated $302M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q4 2023 buy was Pioneer Natural Resource Co.: 240,096 shares worth $54M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Texas Instruments in Q4 2023, an estimated $101M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q4 2023 reduction was Lam Research, cutting an estimated $74.4M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Adobe in Q4 2023, selling an estimated $302M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 30% of its $22.7B portfolio in Q4 2023.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 38 new positions and closed 125 in Q4 2023.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 7% quarter-over-quarter to $22.7B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2023, filed 13 Feb 2024.